company background image
4162 logo

PharmaEngine TPEX:4162 Stock Report

Last Price

NT$94.50

Market Cap

NT$13.6b

7D

-2.6%

1Y

8.0%

Updated

23 Jul, 2024

Data

Company Financials +

4162 Stock Overview

A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan and Europe.

4162 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth1/6
Past Performance2/6
Financial Health6/6
Dividends2/6

Rewards

Risk Analysis

No risks detected for 4162 from our risk checks.

PharmaEngine, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for PharmaEngine
Historical stock prices
Current Share PriceNT$94.50
52 Week HighNT$122.50
52 Week LowNT$79.80
Beta0.67
11 Month Change0.85%
3 Month Change4.19%
1 Year Change8.00%
33 Year Change48.35%
5 Year Change17.39%
Change since IPO53.75%

Recent News & Updates

Recent updates

Would PharmaEngine, Inc. (GTSM:4162) Be Valuable To Income Investors?

Mar 30
Would PharmaEngine, Inc. (GTSM:4162) Be Valuable To Income Investors?

How Much Did PharmaEngine's(GTSM:4162) Shareholders Earn From Share Price Movements Over The Last Five Years?

Feb 18
How Much Did PharmaEngine's(GTSM:4162) Shareholders Earn From Share Price Movements Over The Last Five Years?

Is PharmaEngine, Inc.'s (GTSM:4162) Stock On A Downtrend As A Result Of Its Poor Financials?

Jan 14
Is PharmaEngine, Inc.'s (GTSM:4162) Stock On A Downtrend As A Result Of Its Poor Financials?

We're Not Counting On PharmaEngine (GTSM:4162) To Sustain Its Statutory Profitability

Dec 10
We're Not Counting On PharmaEngine (GTSM:4162) To Sustain Its Statutory Profitability

Shareholder Returns

4162TW BiotechsTW Market
7D-2.6%1.4%-4.6%
1Y8.0%9.9%31.4%

Return vs Industry: 4162 matched the TW Biotechs industry which returned 8.1% over the past year.

Return vs Market: 4162 underperformed the TW Market which returned 29.3% over the past year.

Price Volatility

Is 4162's price volatile compared to industry and market?
4162 volatility
4162 Average Weekly Movement4.2%
Biotechs Industry Average Movement5.5%
Market Average Movement4.7%
10% most volatile stocks in TW Market8.6%
10% least volatile stocks in TW Market2.2%

Stable Share Price: 4162 has not had significant price volatility in the past 3 months.

Volatility Over Time: 4162's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2002n/aHong-Ren Wangwww.pharmaengine.com

PharmaEngine, Inc., a biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan and Europe. It offers ONIVYDE, a novel and stable encapsulated chemotherapy drug irinotecan for the treatment of metastatic pancreatic cancer and other indications of clinical development. The company is developing PEP07, a checkpoint kinase 1 inhibitor, which is in preclinical development stage for the treatment of hematologic cancers and solid cancers, such as acute myeloid leukemia and mantle cell lymphoma.

PharmaEngine, Inc. Fundamentals Summary

How do PharmaEngine's earnings and revenue compare to its market cap?
4162 fundamental statistics
Market capNT$13.58b
Earnings (TTM)NT$275.00m
Revenue (TTM)NT$763.81m

49.4x

P/E Ratio

17.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4162 income statement (TTM)
RevenueNT$763.81m
Cost of RevenueNT$46.11m
Gross ProfitNT$717.69m
Other ExpensesNT$442.70m
EarningsNT$275.00m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Jul 25, 2024

Earnings per share (EPS)1.91
Gross Margin93.96%
Net Profit Margin36.00%
Debt/Equity Ratio0%

How did 4162 perform over the long term?

See historical performance and comparison

Dividends

1.6%

Current Dividend Yield

78%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.